Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07086131 · ClinicalTrials.gov registry record · NA

A Study Investigating the Impact of IMT With CR On Exercise Responses In HF

A NA study of Heart Failure With Reduced Ejection Fraction, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT07086131: Recruiting NA study of Heart Failure With Reduced Ejection Fraction, sponsored by Mayo Clinic.

NCT07086131 is a NA study of Heart Failure With Reduced Ejection Fraction that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 70 participants, below the 3,963-participant average among 27 other Heart Failure With Reduced Ejection Fraction trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07086131, a NA study of Heart Failure With Reduced Ejection Fraction, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the impact of inspiratory muscle training (IMT) combined with cardiac rehabilitation (CR) on cardiovascular function in patients with heart failure.

Primary Outcome

Locomotor muscle blood flows will be measured via Doppler-ultrasound. This will be measured in mL/min.

Conditions Studied

Heart Failure With Reduced Ejection Fraction

Interventions

  • DEVICE Powerbreathe

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2025-09-04
Est. Completion 2029-08
Phase NA
Mayo Clinic

2,844 total trials

What NCT07086131 shows while recruiting

NCT07086131 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 3,963-participant average among 27 other Heart Failure With Reduced Ejection Fraction trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Heart Failure With Reduced Ejection Fraction appearing as the primary indexed condition, and to 1 intervention - of which Powerbreathe is the first listed.

NCT07086131 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT07086131 about?

NCT07086131 is a clinical study titled "A Study Investigating the Impact of IMT With CR On Exercise Responses In HF". The purpose of this study is to compare the impact of inspiratory muscle training (IMT) combined with cardiac rehabilitation (CR) on cardiovascular function in patients with heart failure.

What is the current status of trial NCT07086131?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2025-09-04. Estimated completion is 2029-08.

What conditions does trial NCT07086131 study?

This clinical trial studies the following conditions: Heart Failure With Reduced Ejection Fraction.

What interventions are being tested in trial NCT07086131?

The interventions under investigation include: Powerbreathe (DEVICE).

Who is sponsoring clinical trial NCT07086131?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07086131 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Failure With Reduced Ejection Fraction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07086131's enrollment target sits among peer trials

70 19th of 27 higher than 9 of 27 other Heart Failure With Reduced Ejection Fraction trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure With Reduced Ejection Fraction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT07086131

Source: ClinicalTrials.gov NCT07086131, the US trial registry maintained by the National Library of Medicine. NCT07086131 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.